NCT01841099View on ClinicalTrials.gov

Mesalamine in Environmental Enteropathy

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2014

Conditions
Malnutrition
Interventions
DRUG

Mesalamine

Mesalamine granules

DRUG

Placebo granules

Provided by Ferring Pharma

Trial Locations (1)

Unknown

Baraka Clinic, Nairobi

All Listed Sponsors
collaborator

Imperial College London

OTHER

lead

Kelsey Jones

OTHER

NCT01841099 - Mesalamine in Environmental Enteropathy | Biotech Hunter | Biotech Hunter